USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/4891
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMatcovschi, Sergiu
dc.contributor.authorDumitraş, Tatiana
dc.contributor.authorGuţu-Bahov, Cornelia
dc.contributor.authorSidorenko, Ludmila
dc.contributor.authorTalmaci, Cornelia
dc.contributor.authorNicolenco, Ion
dc.date.accessioned2019-06-25T21:51:55Z
dc.date.available2019-06-25T21:51:55Z
dc.date.issued2012
dc.identifier.citationMATCOVSCHI, Sergiu, DUMITRAŞ, Tatiana et al. Dexametazon în tratamentul pneumoniilor comunitare severe. In: Anale ştiinţifice ale USMF “Nicolae Testemiţanu”. Ed. a 13-a. Chişinau: СEP Medicina, 2012, vol. 3: Probleme actuale în medicina internă, pp. 247-251.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/4891
dc.descriptionClinica Medicală nr. 1, Departamentul Medicină internă Catedra Anesteziologie şi Reanimatologie nr. 2 Secţia Reanimare, IMSP SCM „Sfânta Treime”en_US
dc.description.abstractCurrently glucocorticosteroid treatment of septic conditions, including severe pneumonia, constitutes a controversial topic in the literature. In our retrospective study of 75 cases of severe community-acquired pneumonia, 36 patients received additional treatment with dexamethasone. Applying Cox regression model we demonstrated that additional treatment with dexamethasone does not contribute to a better survival of patients with severe community-acquired pneumonia. Actualmente tratamentul cu glucocorticosteroizi al stărilor septice, inclusiv a pneumoniilor severe, constituie un subiect controversat în literatura de specialitate. În studiul nostru retrospectiv dintre 75 cazuri de pneumonie comunitară severă, 36 pacienţi au primit tratamentul adiţional cu dexametazon. Aplicând modelul regresiunii Cox am demonstrat că tratamentul adiţional cu dexametazon nu contribuie la o supravieţuire mai bună a pacienţilor cu pneumonie comunitară severă.en_US
dc.language.isoroen_US
dc.publisherCEP Medicinaen_US
dc.subject.meshDexamethasoneen_US
dc.subject.meshPneumonia - drug therapyen_US
dc.subject.meshSurvivalen_US
dc.subject.meshRetrospective Studiesen_US
dc.subject.meshDrug Therapy, Combinationen_US
dc.titleDexametazon în tratamentul pneumoniilor comunitare severeen_US
dc.title.alternativeDexamethasone in the treatment of severe community-acquired pneumoniaen_US
dc.typeArticleen_US
Appears in Collections:Pulmonologie

Files in This Item:
File Description SizeFormat 
DEXAMETAZON_IN_TRATAMENTUL_PNEUMONIILOR_COMUNITARE_SEVERE.pdf199.24 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback